pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 10·1 min read
save

Senator John Fetterman's post-stroke conduct sparks debate on brain health and politics

Sep 10, 2026·read at STAT ↗Negative

Neurologists Michael P.H. Stanley and Isaiah Kletenik wrote an opinion piece highlighting how Senator John Fetterman's behavior after his 2022 stroke has become a focal point for discussions about brain health on Capitol Hill. They note that his recent political statements and actions have drawn sharp criticism from colleagues and the media.

A Wall Street Journal investigation reported that the senator missed the majority of hearings, dismissed hospital officials, and made controversial remarks about a police funeral, prompting rebukes from fellow Democrats who called his conduct "lazy" and a "disgrace." The piece contrasts these reactions with earlier praise that framed Fetterman as an inspiring figure despite his language impairments.

The authors argue that the underlying medical context of his stroke is often ignored in the political discourse, suggesting that a better understanding of post‑stroke cognitive changes could inform more compassionate and accurate commentary on his performance.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: John Fetterman’s post-stroke, politically problematic behaviors offer lessons about brain health on Capitol Hill”

read at STAT ↗
1,396 words · retrieved Sep 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Disc Medicine, Inc.WM TECHNOLOGY, INC.
drugs
iron
topics
Neurology3Major Depression2Alzheimer's DiseaseCardiologyPsychiatry & CNSVaccines

related stories

  • Jul 28After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Soufflé cooks up $135M; Matchpoint makes $150MFierce Biotech
  • 5d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Sep 22Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assetsFierce Biotech
  • Sep 17Opinion: What happened to oppositional defiant disorder?STAT